10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
12.86
-0.27 (-2.06%)
At close: Sep 17, 2025, 3:59 PM
13.25
3.03%
Pre-market: Sep 18, 2025, 06:58 AM EDT

10x Genomics Statistics

Share Statistics

10x Genomics has 124.48M shares outstanding. The number of shares has increased by 3.62% in one year.

124.48M
3.62%
2.08%
92.01%
110.42M
14,357
0.43%

Short Selling Information

The latest short interest is 13.74M, so 11.03% of the outstanding shares have been sold short.

13.74M
11.03%
17.71%
6.31

Valuation Ratios

The PE ratio is -9.47 and the forward PE ratio is -13.68. 10x Genomics's PEG ratio is 0.31.

-9.47
-13.68
2.83
2.6
2.44
-301.92
0.31
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for 10x Genomics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.12.

4.97
4.26
0.12
-0.62
-14.42
-48639.75

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$467.68K
$-139.84K
1,306
0.66
2.36

Taxes

4.93M
-2.77%

Stock Price Statistics

The stock price has increased by -41.76% in the last 52 weeks. The beta is 2, so 10x Genomics's price volatility has been higher than the market average.

2
-41.76%
13.23
11.96
45.6
3,305,693

Income Statement

In the last 12 months, 10x Genomics had revenue of 610.78M and earned -182.63M in profits. Earnings per share was -1.52.

610.78M
414.48M
-194.56M
-182.63M
-133.99M
-177.7M
-1.52
Full Income Statement

Balance Sheet

The company has 344.07M in cash and 82.61M in debt, giving a net cash position of 261.45M.

344.07M
82.61M
261.45M
-1.47B
979.97M
543.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.66M and capital expenditures -12.39M, giving a free cash flow of -5.73M.

6.66M
-12.39M
-5.73M
-0.05
Full Cash Flow Statement

Margins

Gross margin is 67.86%, with operating and profit margins of -31.85% and -29.9%.

67.86%
-31.85%
-29.09%
-29.9%
-21.94%
-31.85%
-0.94%

Dividends & Yields

TXG does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for TXG is $15, which is 16.6% higher than the current price. The consensus rating is "Hold".

$15
16.6%
Hold
12
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jul 17, 2006. It was a backward split with a ratio of 1:2.

Jul 17, 2006
backward
1:2

Scores

3.74
5